N-Ethyl-4-hydroxypiperidine, 95.0%, 1g

p-Tolyl isobutyrate, 97%, 25g

1,2-Bis(m-tolyloxy)ethane, 97%, 1g

Regorafénib N-oxyde (M2), 10mg

Naphtho[1,2-c:5,6-c']difuran-1,3,6,8-tetraone>95.0%(HPLC)(T)1g

3-(tert-Butyl)-1-methyl-1H-pyrazole-5-carbohydrazide, 95.0%, 5g

4-(1-((S)-2-((isopropoxycarbonyl)amino)-3-methylbutanamido)ethyl)benzoic acid, 95%, 100mg

3,4-Dichloroisothiazole-5-carbonitrile, 97.0%, 1g

2-(piperidin-3-yl)-4,5,6,7-tetrahydro-1H-benzo[d]imidazole dihydrochloride, 95.0%, 500mg

4-(4-Ethylphenyl)-4-oxobutyric acid, 95.0%, 100g

6-BROMO-2-CHLORO-5-METHOXYBENZO[D]THIAZOLE, 95.0%, 250mg

4-(3-Bromo-4-methoxyphenyl)butan-2-one, 98%, 1g

Bis(trifluoromethanesulfonyl)methyltetrafluorophenyl Polystyrene Resin cross-linked with 2% DVB (200-400mesh) (0.9-1.2mmol/g)100mg